Leo Pharma (Australia)

Recent papers from Leo Pharma (Australia)

1. Design, synthesis, antibacterial and antitubercular evaluation of novel imidazolinone–benzenesulfonamide derivativesJournal of Sulfur Chemistry · 2026
2. Real-world evidence on off-label underdosing of direct oral anticoagulants in Asian patients with atrial fibrillation: prescribing patterns, determinants, and outcomesFuture Science OA · 2026
3. Warming-dredging acupuncture for cancer-related pain: a systematic review and meta-analysisFrontiers in Pain Research · 2026
4. Intralesional human papillomavirus vaccination for cutaneous verrucae: a systematic review and meta-analysis of therapeutic efficacyJournal of Dermatological Treatment · 2026
5. Achieving Canadian Treat-to-Target Criteria in Moderate-to-Severe Atopic Dermatitis: A Retrospective Analysis of Outcomes from Real-World Canadian PracticeDermatology and Therapy · 2026
6. A retrospective cross-sectional study on newborn screening and prevalence of disorders among UAE populationFrontiers in Pediatrics · 2026
7. Lanthionine synthetase C-like protein 1 (LanCL1): a therapeutic target for neuropathic painPain · 2026
8. Budget impact analysis of delgocitinib for moderate to severe Chronic Hand Eczema in the United StatesJournal of Medical Economics · 2026
9. A phase 3 trial of adagloxad simolenin/OBI-821 in patients with high-risk early-stage triple-negative breast cancer.Journal of Clinical Oncology · 2026
10. Advances and Challenges in Raman and Surface-Enhanced Raman Spectroscopy for Biological SystemsACS Applied Bio Materials · 2026
11. Comparative real-world Progression Free Survival of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Patients with Bone MetastasesThe Oncologist · 2026
12. Hand eczema in US employees: a retrospective observational study of workers’ compensation and medical claimsJournal of Medical Economics · 2026
13. Abstract 1730: Guide-effector bsADCs: Driving co-endocytosis for enhanced payload deliveryCancer Research · 2026
14. Abstract 1729: OBI-904, a next-generation nectin-4-targeting exatecan ADC, demonstrates enhanced cytotoxicity and overcomes enfortumab vedotin resistanceCancer Research · 2026
15. Health-related quality of life in individuals with Chronic hand eczema – Findings from the multinational CHECK studyJournal of Dermatological Treatment · 2026
16. Nationwide Incidence, Treatment Pattern, and Prognosis of Primary CNS Lymphoma in Taiwan, 2012–2020: A Retrospective Cohort StudyCancer Medicine · 2026
17. Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patientsBiomarker Research · 2026
18. LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trialNature Communications · 2026
19. Moderate to severe Chronic Hand Eczema in clinical practice: etiological subtypes, clinical signs and symptoms, and comorbidities—results from the RWEAL studyJournal of Dermatological Treatment · 2026
20. Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial designBMC Cancer · 2025